Canakinumab vs triamcinolone acetonidePain: at 72 hours (canakinumab 150 mg) · acute gout1 finding from 1 reviewInterleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 443 participantsModerate